Evidence grade: WEAK — Supported only by weak or preliminary evidence.
computed from the encoded evidence by the Atlas grading rule.
ADC + dynamic time-intensity curves separate many malignant from benign and pleomorphic adenoma/Warthin
Overlap persists (cellular benign tumors low ADC), thresholds are non-standard, and biopsy/surgery still governs
Guides extent of surgery and nerve-sparing; misclassification changes operative approach.
This is an educational research resource from Resonant Labs, not clinical advice. Evidence grades and controversies are summarized from the literature and may change as the field evolves.